Projected to reach US$1,139 billion (£852 billion) by 2029, the injectable drug delivery market is rapidly growing—but what’s driving this evolution? From complex biologics and increased demand for patient self-administration to advanced delivery technologies, the answers will be centre stage at this year’s Injectable Drug Delivery Conference.
“THIS IS THE PERFECT OPPORTUNITY TO BENCHMARK YOUR DRUG DELIVERY PROGRAMME AND OPTIMISE THE DEVELOPMENT OF YOUR INJECTABLE PORTFOLIO.”
SAE Media Group is delighted to welcome key players from the pharmaceutical and biotech community to London, UK, June 24–25, 2025, for two days of industry-leading insights, cross-sector collaboration, and innovation shaping the future of parenteral therapeutics.
Co-chair Rachel Koppelman, Head of Device Engineering at Sandoz, said of the event: “This is the perfect opportunity to benchmark your drug delivery programme and optimise the development of your injectable portfolio.”
SPOTLIGHT SESSIONS: MEET THE 2025 INDUSTRY LEADERS
The 2025 agenda features expert-led case studies and panel debates on device design, materials science, regulatory strategy, and combination product development.
Confirmed spotlight speakers include:
- Rachel Koppelman, Head of Device Engineering, Sandoz
- Joel Richard, Executive Head, Product Development, DBV Technologies
- Conor O’Neill, Head of Packaging Development and Design, GSK
- Chantal Pfaffen, Global Lead Material Qualification, CSL Behring
- Clovis Pichon, Head of Device Program Leadership, UCB Pharma
See the full list of expert speakers on the Speakers Page.
WHO’S ATTENDING: A GLIMPSE AT THE GLOBAL NETWORK
With under six weeks to go, confirmed attendees include experts from Pfizer, GSK, CSL Behring, Sanofi, Roche, Sandoz, UCB Medical Devices, West Pharmaceutical Services, MedinCell, and more. Delegates span senior leadership, R&D, packaging, device engineering, formulation and regulatory affairs—ensuring a diverse and high-value networking environment.
This year’s agenda is built around the most urgent challenges and boldest opportunities in injectable drug delivery, including:
- Subcutaneous delivery of biologics and peptides
- Large-volume and long-acting injectables
- Sustainable device development and material sourcing
- Extractables/Leachables, biocompatibility and toxicology
To confirm your place at the industry’s injectable drug delivery event and take advantage of this opportunity to engage with leading voices, forge meaningful partnerships, and stay ahead of the innovation curve, visit the event website, here.
SAE’s Injectable Drug Delivery 2025 takes place in London, UK on June 24–25, 2025.